Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 727 | 652 | 1,064 | 2,108 | 611 |
| Receivables | 986 | 962 | 1,067 | 589 | 1,574 |
| Inventories | 503 | 412 | 407 | 483 | 429 |
| Other current assets | 0 | 0 | 0 | 41 | 42 |
| TOTAL | $3,857 | $3,722 | $4,269 | $5,607 | $5,086 |
| Non-Current Assets | |||||
| PPE Net | 7,998 | 8,127 | 8,184 | 8,026 | 8,170 |
| Investments And Advances | 5,157 | 5,160 | 5,193 | 5,356 | 5,421 |
| Intangibles | 0 | 0 | 592 | 0 | 0 |
| Other Non-Current Assets | 1,530 | 1,567 | 1,015 | 2,450 | 5,543 |
| TOTAL | $14,684 | $14,853 | $14,984 | $15,833 | $19,134 |
| Total Assets | $18,542 | $18,575 | $19,253 | $21,439 | $24,220 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 345 | 447 | 447 | 419 | 400 |
| Accounts payable and accrued liabilities | 587 | 615 | 601 | 292 | 367 |
| Accrued Expenses | 475 | 309 | 467 | 724 | 937 |
| Other current liabilities | 222 | 284 | 311 | 495 | 478 |
| TOTAL | $3,428 | $1,655 | $1,825 | $3,866 | $4,118 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,800 | 1,800 | N/A | N/A |
| Other Non-Current Liabilities | 649 | 656 | 821 | 1,012 | 4,233 |
| TOTAL | $649 | $2,457 | $2,453 | $1,913 | $4,924 |
| Total Liabilities | $4,077 | $4,112 | $4,278 | $5,779 | $9,043 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,481 | 7,054 | 6,980 | 6,006 | 6,006 |
| Common Shares | 1 | 7 | 1 | 6 | 6 |
| Retained earnings | -40,946 | -40,331 | -39,697 | -37,805 | -38,116 |
| Other shareholders' equity | -1,267 | -1,466 | -1,483 | -1,363 | -1,535 |
| TOTAL | $14,465 | $14,464 | $14,974 | $15,660 | $15,177 |
| Total Liabilities And Equity | $18,542 | $18,575 | $19,253 | $21,439 | $24,220 |